AstraZeneca and Pieris Collaborate on Inhaled Treatment for Asthma
By Natasha Piper
Pharma Deals Review: Vol 2017 Issue 5 (Table of Contents)
Published: 15 May-2017
DOI: 10.3833/pdr.v2017.i5.2245 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
AstraZeneca (AZ) has agreed to collaborate with Pieris Pharmaceuticals to develop a preclinical-stage inhaled therapeutic, PRS-060, for the treatment of asthma, as well as four other proteins for respiratory disease...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS